GAD2 and encephalitis: The highest prevalence of psychiatric symptoms was in patients with anti-gamma-aminobutyric acid type B (GABAB) encephalitis (83%), and the lowest was in patients with anti-glutamic acid decarboxylase 65 (GAD65) encephalitis (14%).